ArticleJournal of addiction medicine and therapeutic science
Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers.
Article in Journal of addiction medicine and therapeutic science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.
- Smartphone Apps Targeting Alcohol and Illicit Substance Use: Systematic Search in in Commercial App Stores and Critical Content Analysis.JMIR mHealth and uHealth · 2019Pooled it
- "It was good because they have a relationship with us": A qualitative study on low-threshold buprenorphine treatment at syringe services programs.Journal of substance use and addiction treatment · 2026Trial
- Using structured analysis and design technique to characterize barriers and facilitators to outpatient care coordination after emergency department-initiated buprenorphine.Journal of substance use and addiction treatment · 2026Article
- Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and Staff.Drug and alcohol review · 2026Article
- Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.Community mental health journal · 2025Article
- Invited commentary: motivating better methods-and better data collection-for measuring the prevalence of drug misuse.American journal of epidemiology · 2025Article
- Buprenorphine use among non-hospital residential programs.Drug and alcohol dependence · 2024Article
- Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey.JMIR research protocols · 2023Article
- Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study.Addiction science & clinical practice · 2022Article
- The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.Addiction science & clinical practice · 2022Article
- Therapeutic relationships between Veterans and buprenorphine providers and effects on treatment retention.Health services research · 2022Article
- Association Between Interorganizational Collaboration in Opioid Response and Treatment Capacity for Opioid Use Disorder in Counties of Five States: A Cross-Sectional Study.Substance abuse : research and treatment · 2022Article
- Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017.Drug and alcohol dependence · 2021Article
- Voting with their feet: Social factors linked with treatment for opioid use disorder using same-day buprenorphine delivered in California hospitals.Drug and alcohol dependence · 2021Article
- A large-scale retrospective study of opioid poisoning in New York State with implications for targeted interventions.Scientific reports · 2021Article
- Increasing Access to Buprenorphine in Safety-Net Primary Care Clinics: The New York City Buprenorphine Nurse Care Manager Initiative.American journal of public health · 2021Article
- "The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed Buprenorphine.Substance use & misuse · 2021Article
- Developments in Mobile Health Just-in-Time Adaptive Interventions for Addiction Science.Current addiction reports · 2020Article
- Leveraging black-market street buprenorphine pricing to increase capacity to treat opioid addiction, 2010-2018.Preventive medicine · 2020Article
- Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.NAM perspectives · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
backgroundSince its U.S. FDA approval in 2002, buprenorphine has been available for maintenance treatment of opiate dependence in primary care physicians' offices. Though buprenorphine was intended to facilitate access to treatment, disparities in utilization have emerged; while buprenorphine treatment is widely used in private care setting, public healthcare integration of buprenorphine lags behind.
resultsThrough a review of the literature, we found that U.S. disparities are partly due to a shortage of certified prescribers, concern of patient diversion, as well as economic and institutional barriers. Disparity of buprenorphine treatment dissemination is concerning since buprenorphine treatment has specific characteristics that are especially suited for low-income patient population in public sector healthcare such as flexible dosing schedules, ease of concurrently treating co-morbidities such as HIV and hepatitis C, positive patient attitudes towards treatment, and the potential of reducing addiction treatment stigma.
conclusionAs the gap between buprenorphine treatment in public sector settings and private sector settings persists in the U.S., current research suggests ways to facilitate its dissemination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.